# Computed tomography perfusion in predicting radiation therapy response in dogs and a cat with head and neck tumors

**Authors:** Soyeon Kim, Eunjee Kim, Min-Ok Ryu, Kyoungwon Seo, Junghee Yoon, Jihye Choi

PMC · DOI: 10.1093/jvimsj/aalaf025 · Journal of Veterinary Internal Medicine · 2026-01-21

## TL;DR

CT perfusion can help predict how well tumors in dogs and cats respond to radiation therapy by measuring blood flow and volume.

## Contribution

The study shows that CT perfusion variables, especially normalized blood volume and flow changes, are reliable early indicators of radiation therapy response.

## Key findings

- Higher blood flow and volume before radiation therapy correlated with greater tumor reduction.
- Normalized perfusion variables like rcBV and pΔBF more accurately reflected tumor size changes than absolute values.
- Perfusion variables increased at day 30 and then declined by day 90 after treatment.

## Abstract

Predicting tumor response to radiation therapy (RT) is challenging, as conventional assessment primarily considers morphology. Computed tomography (CT) perfusion might provide early prediction by evaluating tumor oxygenation and vascularity.

To evaluate the association between CT perfusion variables and tumor size reduction, and their potential to predict outcomes after RT.

Eleven dogs and 1 cat with malignant head and neck tumors, including squamous cell carcinoma, melanoma, and adenocarcinoma.

This retrospective study evaluated CT perfusion and tumor size before RT, and at 0, 30, and 90 days after RT. Perfusion variables, including blood flow (BF), blood volume (BV), and flow extraction (FE), were measured as absolute values and normalized to contralateral tissue (rc) and muscle (rm). Changes were compared with the previous (pΔ) and following (fΔ) examinations.

Median values before RT were BV 29.7 mL/100 mL, BF 229.9 mL/min/100 mL, and FE 39.5 mL/min/100 mL. Tumor volumes were generally smaller after RT. The perfusion variables increased at day 30, and subsequently declined by day 90. The rcBV and early increases in BF (pΔBF) were associated with change in tumor size. Higher BF or BV before RT correlated with greater tumor reduction. The change in rmBV relative to the previous scan (pΔrmBV) also correlated with sequent tumor size changes.

Computed tomography perfusion could offer functional biomarkers for early RT response assessment. Higher BF and BV before RT were associated with better outcomes, and normalized variables, particularly rcBV and pΔBF more reliably reflected tumor size changes than absolute values.

## Linked entities

- **Diseases:** squamous cell carcinoma (MONDO:0005096), melanoma (MONDO:0005105), adenocarcinoma (MONDO:0004970)

## Full-text entities

- **Diseases:** Head and neck tumors (MESH:D006258), nasal epithelial tumors (MESH:D002277), Adenocarcinoma (MESH:D000230), Tumor (MESH:D009369), inflammatory (MESH:D007249), Melanoma (MESH:D008545), SCC (MESH:D002294), head and neck SCC (MESH:D000077195), hypoxia (MESH:D000860), sarcomas (MESH:D012509), epileptic drugs (MESH:D000069279), hyperemia (MESH:D006940), hypoxic (MESH:D002534), metastases (MESH:D009362), nasal tumors:7 (MESH:D009669), Solid (MESH:D018250), necrosis (MESH:D009336)
- **Chemicals:** Midazolam (MESH:D008874), oxygen (MESH:D010100), propofol (MESH:D015742), isoflurane (MESH:D007530), Alfaxan (MESH:C006477), carboplatin (MESH:D016190), Jurox (-), gabapentin (MESH:D000077206), iodine (MESH:D007455), gadolinium (MESH:D005682)
- **Species:** Canis lupus familiaris (dog, subspecies) [taxon 9615], Felis catus (cat, species) [taxon 9685], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12881964/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12881964/full.md

## References

36 references — full list in the complete paper: https://tomesphere.com/paper/PMC12881964/full.md

---
Source: https://tomesphere.com/paper/PMC12881964